Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Avantor
AVTR
$9.86B
| $2.45M | ﹤0.01% |
60,000
+30,000
| +100% | +$1.17M |
|
3627
National Bank Holdings
NBHC
$1.84B
| $2.45M | ﹤0.01% |
60,617
-154,127
| -72% | -$5.63M |
|
|
HMCOU
3628
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
| $2.45M | ﹤0.01% |
239,800
| – | – |
|
3629
Beyond Air
XAIR
$4.41M
| $2.45M | ﹤0.01% |
551
-125
| -18% | -$453K |
|
3630
Vanguard Morningstar Growth ETF
VUG
$228B
| $2.45M | ﹤0.01% |
50,646
+22,362
| +79% | +$1.11M |
|
|
HOLI
3631
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.45M | ﹤0.01% |
118,246
+86,261
| +270% | +$1.58M |
|
|
FUV
3632
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $2.45M | ﹤0.01% |
10,702
+7,616
| +247% | +$2.07M |
|
3633
Enerpac Tool Group
EPAC
$1.92B
| $2.44M | ﹤0.01% |
117,660
+57,654
| +96% | +$1.44M |
|
3634
BayCom
BCML
$331M
| $2.44M | ﹤0.01% |
131,066
-54,954
| -30% | -$983K |
|
|
APTX
3635
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.44M | ﹤0.01% |
1,041,392
-86,320
| -8% | -$220K |
|
|
NARI
3636
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2.43M | ﹤0.01% |
30,000
+10,000
| +50% | +$840K |
|
3637
CALL
Blackrock
BLK
$180B
| $2.43M | ﹤0.01% |
2,900
+2,100
| +263% | +$1.88M |
|
|
CMA
3638
PUT
DELISTED
Comerica
CMA
| $2.43M | ﹤0.01% |
30,200
+25,800
| +586% | +$1.86M |
|
3639
Seer Inc
SEER
$110M
| $2.43M | ﹤0.01% |
70,353
+54,727
| +350% | +$1.88M |
|
3640
CNX Resources
CNX
$5.36B
| $2.43M | ﹤0.01% |
192,355
+81,901
| +74% | +$991K |
|
3641
B2Gold
BTG
$7.48B
| $2.43M | ﹤0.01% |
709,557
+616,871
| +666% | +$2.38M |
|
3642
Fennec Pharmaceuticals
FENC
$430M
| $2.43M | ﹤0.01% |
257,621
-147,151
| -36% | -$1.1M |
|
3643
iShares MSCI Indonesia ETF
EIDO
$491M
| $2.42M | ﹤0.01% |
111,638
-233,787
| -68% | -$4.85M |
|
3644
Barings BDC
BBDC
$979M
| $2.42M | ﹤0.01% |
219,471
-48,333
| -18% | -$521K |
|
3645
Corcept Therapeutics
CORT
$12.3B
| $2.42M | ﹤0.01% |
122,844
+13,618
| +12% | +$285K |
|
|
EVRI
3646
CALL
DELISTED
Everi Holdings
EVRI
| $2.42M | ﹤0.01% |
+100,000
| New | +$2.28M |
|
|
RAD
3647
CALL
DELISTED
Rite Aid Corporation
RAD
| $2.41M | ﹤0.01% |
170,000
+50,000
| +42% | +$787K |
|
3648
CALL
Baxter International
BAX
$13.5B
| $2.41M | ﹤0.01% |
30,000
-245,000
| -89% | -$19.4M |
|
3649
Northeast Bank
NBN
$1.11B
| $2.41M | ﹤0.01% |
71,463
-58,729
| -45% | -$1.88M |
|
3650
Watts Water Technologies
WTS
$12.2B
| $2.41M | ﹤0.01% |
14,329
-3,466
| -19% | -$555K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.